XML 58 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Recapitalization - Narrative (Details)
 7 Months Ended 12 Months Ended
Aug. 16, 2021
USD ($)
$ / shares
shares
Aug. 15, 2021
$ / shares
shares
Aug. 12, 2021
USD ($)
$ / shares
shares
Aug. 15, 2021
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Dec. 31, 2019
shares
Schedule Of Reverse Recapitalization [Line Items]              
Common stock and preferred stock — shares authorized (in shares) 301,000,000            
Common stock — shares authorized (in shares) 300,000,000       300,000,000 300,000,000  
Common stock — par value (in dollars per share) | $ / shares $ 0.0001       $ 0.0001 $ 0.0001  
Preferred stock — shares authorized (in shares) 1,000,000       1,000,000 1,000,000  
Preferred stock — par value (in dollars per share) | $ / shares $ 0.0001       $ 0.0001 $ 0.0001  
Exchange ratio 3.7208            
Convertible preferred stock conversion ratio   1   1      
Warrant exercise price (in dollars per share) | $ / shares $ 11.50       $ 11.50    
Common stock conversion ratio   1   1      
Warrant period exercisable 30 days            
Warrant expiration period 5 years            
Transaction costs recorded to additional paid-in capital | $ $ 52,661,000            
Transaction costs expensed | $ 2,198,000            
Gross proceeds from Business Combination | $ $ 256,811,000            
PIPE Subscription, All Investors              
Schedule Of Reverse Recapitalization [Line Items]              
Shares issued in transaction (in shares) 22,000,000            
Purchase price (in dollars per share) | $ / shares $ 10.00            
Aggregate purchase price | $ $ 220,000,000            
PIPE Subscription, Defaulted Investor              
Schedule Of Reverse Recapitalization [Line Items]              
Shares issued in transaction (in shares) 500,000            
Purchase price (in dollars per share) | $ / shares $ 10.00            
Aggregate purchase price | $ $ 5,000,000            
AEye Technologies | Common Stock Warrants              
Schedule Of Reverse Recapitalization [Line Items]              
Outstanding warrants exercised (in shares)   61,612   61,612      
Net settlement of common stock and Series A preferred stock warrants (in shares)   57,770          
Warrant exercise price (in dollars per share) | $ / shares   $ 37.21   $ 37.21      
AEye Technologies | Series A Preferred Warrants              
Schedule Of Reverse Recapitalization [Line Items]              
Outstanding warrants exercised (in shares)   7,353   7,353      
Net settlement of common stock and Series A preferred stock warrants (in shares)   6,949          
Warrant exercise price (in dollars per share) | $ / shares   $ 37.21   $ 37.21      
CF III              
Schedule Of Reverse Recapitalization [Line Items]              
Redemption of shares (in shares)     19,355,365        
Value of redemption of shares | $     $ 195,498,000        
Redemption price per share (in dollars per share) | $ / shares     $ 10.10        
Common Stock              
Schedule Of Reverse Recapitalization [Line Items]              
Conversion of Convertible Notes and Accrued Interest (in shares) 20,778,097     20,778,097 20,778,097    
Shares outstanding (in shares)         155,137,237 101,286,645 102,945,482
Net settlement of common stock and Series A preferred stock warrants (in shares)       240,806 240,806    
Redemption of shares (in shares)           3,536,070  
Common Stock | Retroactive application of recapitalization              
Schedule Of Reverse Recapitalization [Line Items]              
Shares outstanding (in shares)           90,448,635 91,661,644
Common Stock | AEye Technologies              
Schedule Of Reverse Recapitalization [Line Items]              
Conversion of Convertible Notes and Accrued Interest (in shares)   5,584,308   5,584,308      
Shares outstanding (in shares)             11,283,838
Net settlement of common stock and Series A preferred stock warrants (in shares)       64,719      
Redemption of shares (in shares)           950,352  
Preferred Stock              
Schedule Of Reverse Recapitalization [Line Items]              
Shares outstanding (in shares)         0 0 0
Preferred Stock | Retroactive application of recapitalization              
Schedule Of Reverse Recapitalization [Line Items]              
Shares outstanding (in shares)           (16,383,725) (16,383,725)
Preferred Stock | AEye Technologies              
Schedule Of Reverse Recapitalization [Line Items]              
Shares outstanding (in shares)             16,383,725
Preferred Stock | AEye Technologies | Retroactive application of recapitalization              
Schedule Of Reverse Recapitalization [Line Items]              
Shares outstanding (in shares)   16,383,725   16,383,725